$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-009/28
  • A61K-009/32
  • A61K-009/52
  • A61K-009/56
  • A61K-009/58
출원번호 US-0800593 (2001-03-06)
발명자 / 주소
  • Patel, Mahesh V.
  • Chen, Feng-Jing
출원인 / 주소
  • Lipocine, Inc.
대리인 / 주소
    Reed, Dianne E.Reed & Eberle LLP
인용정보 피인용 횟수 : 378  인용 특허 : 15

초록

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a

대표청구항

The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a solid carrier, the solid carrier including a

이 특허에 인용된 특허 (15)

  1. Bagaria Suresh C. (Somerset NJ) Lordi Nicholas G. (Bloomfield NJ), Aqueous dispersions of waxes and lipids for pharmaceutical coating.
  2. Gilis Paul M. V. (Schransdriesstraat 14 B-2340-Beerse BEX) De Conde Valentin F. V. (Kolonie 57 B-3920-Lommel BEX) Vandecruys Roger P. G. (Langstraat 108 B-2260-Westerlo BEX), Beads having a core coated with an antifungal and a polymer.
  3. Geyer Robert P. (c/o Affinity Biotech ; Inc. ; 305 Chelsea Pkwy. Boothwyn PA 19061) Tuliani Vinod V. (c/o Affinity Biotech ; Inc. ; 305 Chelsea Pkwy. Boothwyn PA 19061), Chewable drug-delivery compositions and methods for preparing the same.
  4. Santus Giancarlo (Milan ITX) Bottoni Giuseppe (Bergamo ITX) Lazzarini Caterina (Milan ITX), Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide.
  5. Lacy Jonathan Ernest (Swindon GBX) Embleton Jonathan Kenneth (Berkshire GBX), Delivery systems for hydrophobic drugs.
  6. Patel Nagin K. (1914 W. 5th St. Brooklyn NY 11223), Drug in bead form and process for preparing same.
  7. Stetsko Gregg (Bethlehem NY) Chang Kuei-Tu (Mountain Lakes NJ), Low solubility drug-coated bead compositions.
  8. Sangekar Surendra A. ; Vadino Winston A. ; Lee Ping I., Oral antifungal composition.
  9. Cho Young W. (Chester NJ), Pharmaceutical compositions.
  10. Yano Katsuhiko (Fujieda JPX) Nishizono Yasuhiro (Urawa JPX) Yamazaki Shigeru (Fujieda JPX) Ohmura Tadayoshi (Fujieda JPX) Hasumi Shunji (Fujieda JPX), Quick-dissolution solid preparation.
  11. Desieno Mark A. (Gilbertsville PA) Stetsko Gregg (Harleysville PA), Redispersible nanoparticulate film matrices with protective overcoats.
  12. Amselem Shimon,ILX, Solid Coprecipitates for enhanced bioavailability of lipophilic substances.
  13. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  14. Gibson Lowell L. ; Hartauer Kerry J. ; Stowers Julian L. ; Sweetana Stephanie A. ; Thakkar Arvind L., Solid orally administerable raloxifene hydrochloride pharmaceutical formulation.
  15. Harrison Paul J. (Alnwick GB2) Langridge John R. (Alnwick GB2) Potter Christopher J. (Alnwick GB2), Unit dosage form of sparingly soluble medicaments.

이 특허를 인용한 특허 (378)

  1. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  2. Du, Jinfa; Sofia, Michael Joseph, 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections.
  3. Swann, Jim; Cummins, Peter, Acetaminophen / ibuprofen combinations and method for their use.
  4. Swann, Jim; Cummins, Peter, Acetaminophen/ibuprofen combinations and method for their use.
  5. Petkovich, P. Martin; Melnick, Joel Z.; White, Jay A.; Tabash, Samir P.; Bishop, Charles W.; Peers, Susan; Strugnell, Stephen A., Adjunctive therapy with 25-hydroxyvitamin D and articles therefor.
  6. Rudnic,Edward M., Antibiotic composition with inhibitor.
  7. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  8. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  9. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  10. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  11. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  12. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  13. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  14. Li,Danping; Phusanti,Lawan; Desai,Divyakant S., Antidiabetic formulation and method.
  15. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antifungal once-a-day product, use and formulation thereof.
  16. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  17. Hagen,Timothy A.; Lo,Julian B.; Thombre,Avinash G.; Herbig,Scott M.; Appel,Leah Elizabeth; Crew,Marshall David; Friesen,Dwayne Thomas; Lyon,David Keith; McCray,Scott Baldwin; West,James Blair, Azithromycin dosage forms with reduced side effects.
  18. Howard, William Wayne; Somma, Russell Francis, Benzonatate compositions and methods of use.
  19. Howard, William Wayne; Somma, Russell Francis; Frank, Doreen Marie, Benzonatate compositions and methods of use.
  20. Gelbard, Harris A.; Dewhurst, Stephen; Goodfellow, Val S.; Wiemann, Torsten; Ravula, Satheesh Babu; Loweth, Colin J., Bicyclic heteroaryl kinase inhibitors and methods of use.
  21. Madhavi,Doddabele L.; Kagan,Daniel I., Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems.
  22. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  23. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  24. Harrison, Paul Jonathan; Power, Anna Marie, Bisphosphonate formulation.
  25. Harrison,Paul Jonathan; Power,Anna Marie, Bisphosphonate formulation.
  26. Lane, Heidi; O'Reilly, Terence; Wood, Jeanette Marjorie, Cancer treatment.
  27. Ankner, Charles Everett, Cannabinod formulation for the sedation of a human or animal.
  28. Hoekman, John D.; Ho, Rodney J. Y., Circumferential aerosol device.
  29. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Co-enzyme Q10 formulations and methods of use.
  30. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Co-enzyme Q10 formulations and methods of use.
  31. Udell, Ronald G., Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing.
  32. Went, Gregory T.; Fultz, Timothy J., Composition and method for treating neurological disease.
  33. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  34. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  35. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  36. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  37. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  38. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  39. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  40. Went, Gregory T.; Fultz, Timothy J.; Porter, Seth; Meyerson, Laurence R.; Burkoth, Timothy S., Composition and method for treating neurological disease.
  41. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  42. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo, Composition comprising oil drops.
  43. Angel, Arturo J.; Litle, Larry W.; Bley, Keith R.; Wilcox, Allan L.; Jamieson, Gene Curtis; Muhammad, Naweed, Compositions and kits for the removal of irritating compounds from bodily surfaces.
  44. Angel, Arturo J.; Litle, Larry W.; Bley, Keith R.; Wilcox, Allan L.; Jamieson, Gene Curtis; Muhammad, Naweed, Compositions and kits for the removal of irritating compounds from bodily surfaces.
  45. Flanner, Henry H.; Guttendorf, Robert J.; Clausen, Susan P.; Treacy, Donald; Burnside, Beth A., Compositions and methods for improved efficacy of penicillin-type antibiotics.
  46. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces.
  47. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces.
  48. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces.
  49. Fallon, Joan M., Compositions and use thereof for treating symptoms of preeclampsia.
  50. Singh, Nikhilesh N., Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof.
  51. Singh, Nikhilesh N., Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof.
  52. Singh, Nikhilesh N., Compositions for treating insomnia.
  53. Rubino, Orapin P.; Jones, David M., Controlled release matrix pharmaceutical dosage formulation.
  54. Lenaerts, Vincent; Ouadji-Njiki, Patricia Laure; Bacon, Johnatan; Ouzerourou, Rachid; Gervais, Sonia; Rahmouni, Miloud; Smith, Damon, Controlled-release compositions.
  55. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  56. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  57. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  58. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  59. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  60. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  61. Chang, James N.; Olejnik, Orest; Firestone, Bruce A., Cyclosporin compositions.
  62. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  63. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  64. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  65. Chang,James N.; Olejnik,Orest; Firestone,Bruce A., Cyclosporin compositions.
  66. Ni,Yawei; Yates,Kenneth M., Delivery of physiological agents with in-situ gels comprising anionic polysaccharides.
  67. Amselem, Shimon; Naveh, Michael, Depot formulations of a hydrophobic active ingredient and methods for preparation thereof.
  68. Amselem, Shimon; Naveh, Michael, Depot formulations of a local anesthetic and methods for preparation thereof.
  69. Amselem, Shimon; Naveh, Michael, Depot formulations of a local anesthetic and methods for preparation thereof.
  70. Sasaki, Yasuhiko; Matsumura, Yukihiro; Yamazaki, Masaru; Arai, Hiroshi; Kawabata, Shogo; Saito, Masaaki; Okuyama, Hirohisa; Suzuki, Makoto, Diclofenac sodium patches for topical treatment of pain.
  71. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  72. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  73. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  74. Jarrett, Peter; El-Hayek, Rami; Sawhney, Amarpreet S.; Guedez, Sarah, Drug delivery systems and applications.
  75. Jarrett, Peter; Bassett, Michael; Blizzard, Charles D.; Sawhney, Amarpreet S., Drug delivery through hydrogel plugs.
  76. Sawhney, Amarpreet S.; Jarrett, Peter; Bassett, Michael; Blizzard, Charles, Drug delivery through hydrogel plugs.
  77. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  78. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  79. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  80. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  81. Fallon, Joan; Heil, Matt, Enzyme delivery systems and methods of preparation and use.
  82. Borschke, August Joseph; Holton, Jr., Darrell, Excipients for nicotine-containing therapeutic compositions.
  83. Jaiswal, Sunil Beharilal; Shah, Vaibhavi Ankur; Tiwari, Sunil Deviprasad, Extended release pharmaceutical compositions.
  84. Dixit, Manesh; Cheng, Xiu-Xiu; Nangia, Avinash; Chen, Chin Ming, Extended release venlafaxine formulation.
  85. Dixit,Manesh; Cheng,Xiu Xiu; Nangia,Avinash; Chen,Chih Ming, Extended release venlafaxine formulation.
  86. Ray, Roderick J.; Appel, Leah E.; Newbold, David D.; Friesen, Dwayne T.; McCray, Scott B.; Lyon, David K.; West, James B.; Crew, Marshall D.; Shockey, Joshua R., Extrusion process for forming chemically stable drug multiparticulates.
  87. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  88. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  89. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  90. Sriwongjanya, Mongkol; Yuk, Samuel; Nangia, Avinash, Formulation and process for drug loaded cores.
  91. Sriwongjanya,Mongkol; Yuk,Samuel; Nangia,Avinash, Formulation and process for drug loaded cores.
  92. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres, Formulations.
  93. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Mónica, Formulations.
  94. Buxton, Ian Richard; Karolak, Wlodzimierz; Maleki, Mehran; Iyer, Vijay Mohan, Formulations and method of treatment.
  95. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  96. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  97. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  98. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  99. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  100. Tunac, Josefino B., HDL-boosting combination therapy complexes.
  101. Tunac,Josefino B., HDL-boosting combination therapy complexes.
  102. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, High molecular weight, low methoxyl pectins, and their production and uses.
  103. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  104. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  105. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  106. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  107. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  108. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  109. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  110. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
  111. Madhavi,Doddabele L.; Kagan,Daniel I., Highly bioavailable coenzyme Q-10 cyclodextrin complex.
  112. Aversa, Vincenzo; Coulter, Ivan; Rosa, Mónica Torres; McDonald, Bernard Francis, Immunomodulatory compositions.
  113. Coulter, Ivan; McDonald, Bernard Francis; Aversa, Vincenzo; Rosa, Monica Torres; Lavelle, Edward Charles, Immunomodulatory compositions comprising a polymer matrix and an oil phase.
  114. Ni, Yawei; Yates, Kenneth M., In-situ gel formation of pectin.
  115. Kirsch, John; Nallamothu, Ramakrishna; Polat, Baris E., Levothyroxine formulation with acacia.
  116. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  117. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  118. Stuhl, William J.; Sowden, Harry S.; McNally, Gerard P.; Anderson, Oliver, Machine for production of solid dosage forms.
  119. Sowden, Harry S.; Bunick, Frank J.; Luber, Joseph R.; Kriksunov, Leo B.; Szymczak, Christopher E., Machine for the manufacture of dosage forms utilizing radiofrequency energy.
  120. Sowden, Harry S.; Bunick, Frank J.; Luber, Joseph R.; Kriksunov, Leo B.; Szymczak, Christopher E., Machine for the manufacture of dosage forms utilizing radiofrequency energy.
  121. Koll, Gregory E.; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B.; Bunick, Frank J.; Chen, Jen-Chi; Olsson, Roland; Szymczak, Christopher E., Manufacture of chewing gum product with radiofrequency.
  122. Chen, Jen-Chi; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B.; Bunick, Frank J.; Szymczak, Christopher E.; Koll, Gregory E., Manufacture of lozenge product with radiofrequency.
  123. Chen, Jen-Chi; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B.; Bunick, Frank J.; Szymczak, Christopher E.; Koll, Gregory E., Manufacture of lozenge product with radiofrequency.
  124. Coulter, Ivan, Manufacture of multiple minicapsules.
  125. Coulter, Ivan, Manufacture of multiple minicapsules.
  126. Kriksunov, Leo B.; Sowden, Harry S.; Luber, Joseph R.; Bunick, Frank J., Manufacture of tablet having immediate release region and sustained release region.
  127. Bunick, Frank J.; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B.; Szymczak, Christopher E., Manufacture of tablet in a die utilizing powder blend containing water-containing material.
  128. Bunick, Frank J.; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B.; Szymczak, Christopher E., Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder.
  129. Szymczak, Christopher E.; Bunick, Frank J.; Sowden, Harry S.; Luber, Joseph R.; Kriksunov, Leo B., Manufacture of variable density dosage forms utilizing radiofrequency energy.
  130. Hogan, Michael; Saghbini, Michael; Wong, David, Matrices and media for storage and stabilization of biomolecules.
  131. Hogan, Michael; Saghbini, Michael; Wong, David; Shi, Chunnian, Matrices and media for storage and stabilization of biomolecules.
  132. Jarrett, Peter; El-Hayek, Rami; Sawhney, Amarpreet S., Medical organogel processes and compositions.
  133. Bishop, Charles W.; Tabash, Samir P.; Agudoawu, Sammy A.; White, Jay A.; Messner, Eric J.; Petkovich, P. Martin; Crawford, Keith H., Method for controlled release oral dosage of a vitamin D compound.
  134. Fallon, Joan M., Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy.
  135. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  136. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  137. Coulter, Ivan; Aversa, Vincenzo, Method for treating intestinal fibrosis.
  138. Coulter, Ivan; Aversa, Vincenzo, Method for treating intestinal fibrosis.
  139. Fallon, Joan M., Method for treating pervasive development disorders.
  140. Fallon, Joan M., Method for treating pervasive development disorders.
  141. Fallon, Joan M., Method for treating pervasive development disorders.
  142. Fallon, Joan M., Method for treating pervasive development disorders.
  143. Fallon, Joan M., Method for treating pervasive development disorders.
  144. Bishop, Charles W.; Tabash, Samir P.; Agudoawu, Sammy A.; White, Jay A.; Crawford, Keith H.; Messner, Eric J.; Petkovich, P. Martin, Method for treating secondary hyperparathyroidism in CKD.
  145. Bishop, Charles W.; Tabash, Samir P.; Agudoawu, Sammy A.; White, Jay A.; Messner, Eric J.; Petkovich, P. Martin; Crawford, Keith H., Method for treating secondary hyperparathyroidism in CKD.
  146. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  147. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  148. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  149. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  150. Went, Gregory T.; Sathyan, Gayatri; Vermani, Kavita; Ganapati, Gangadhara; Coffee, Michael; Shek, Efraim; Katdare, Ashok, Method of administering amantadine prior to a sleep period.
  151. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  152. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  153. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  154. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  155. Anderson, Oliver; Sowden, Harry S.; McNally, Gerard P.; Stuhl, William J., Method of manufacturing solid dosage form.
  156. Fallon, Joan M., Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders.
  157. Fallon, Joan M., Method of treating pregnancy-induced hypertension.
  158. Fallon, Joan M., Method of treating proteinuria in pregnancy.
  159. Fallon, Joan M., Method of treating toxemia.
  160. Fallon, Joan M.; Heil, Matthew; Szigethy, James; Fallon, James, Method of treatment of schizophreniform disorder.
  161. Fallon, Joan M.; Heil, Matthew F.; Fallon, James J.; Szigethy, James, Methods and compositions for the treatment of influenza.
  162. Fallon, Joan M., Methods and compositions for the treatment of symptoms of Williams Syndrome.
  163. Fallon, Joan M., Methods and compositions for the treatment of symptoms of prion diseases.
  164. Fallon, Joan M., Methods and compositions for the treatment of symptoms of prion diseases.
  165. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  166. Tidmarsh, George; Golombik, Barry L.; Sharma, Puneet, Methods and medicaments for administration of ibuprofen.
  167. Bishop, Charles W.; Tabash, Samir P.; Agudoawu, Sammy A.; White, Jay A.; Crawford, Keith H.; Messner, Eric J.; Petkovich, P. Martin, Methods for controlled release oral dosage of a vitamin D compound.
  168. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  169. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  170. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  171. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  172. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
  173. Fallon, Joan M., Methods for treating pervasive development disorders.
  174. Narain, Niven Rajin; McCook, John Patrick, Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10).
  175. Went, Gregory T.; Fultz, Timothy J.; McClure, Natalie, Methods of administering amantadine.
  176. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  177. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  178. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  179. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  180. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  181. Acheampong, Andrew; Tang-Liu, Diane D.; Chang, James N.; Power, David F., Methods of providing therapeutic effects using cyclosporin components.
  182. Fallon, Joan M., Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders.
  183. Singh, Nikhilesh; Pather, Sathasivan Indiran, Methods of treating middle-of-the-night insomnia.
  184. Dores, Robert M., Methods of treating overproduction of cortisol using ACTH antagonist peptides.
  185. Narain, Niven Rajin; Sarangarajan, Rangaprasad; Gray, Thomas Mitchell; McCook, John Patrick; Jimenez, Joaquin J., Methods of treatment of cancer by continuous infusion of coenzyme Q10.
  186. Fallon, Joan; Heil, Matthew; Szigethy, James; Fallon, James, Methods of treatment of schizophrenia.
  187. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  188. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  189. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  190. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  191. Theus, Jon Scott, Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same.
  192. Zepp, Charles; Gao, Yun, Modified nicotinic compounds and related methods.
  193. Flanner, Henry H.; Tolle-Sander, Sanna; Treacy, Donald; Burnside, Beth A.; Clausen, Susan P., Modified release amoxicillin products.
  194. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  195. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  196. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  197. Duggins, Donna Walker; Mua, John-Paul; Holton, Jr., Darrell Eugene; Cantrell, Daniel Verdin, Multi-layer nicotine-containing pharmaceutical composition.
  198. Appel, Leah E.; Ray, Roderick J.; Lyon, David K.; West, James B.; McCray, Scott B.; Crew, Marshall D.; Friesen, Dwayne T.; Herbig, Scott M.; Lo, Julian B., Multiparticulate crystalline drug compositions having controlled release profiles.
  199. Hoekman, John D.; Hite, Michael; Brunelle, Alan; Relethford, Joel; Ho, Rodney J. Y., Nasal drug delivery device.
  200. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  201. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  202. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  203. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  204. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  205. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  206. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  207. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  208. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  209. Bernick, Brian A.; Persicaner, Peter H. R.; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  210. Hoekman, John D.; Hite, Michael; Brunelle, Alan; Relethford, Joel, Nozzles for nasal drug delivery.
  211. Bao, Donghui; Chang, Wonsuk; Nagarathnam, Dhanapalan; Sofia, Michael Joseph, Nucleoside analogs.
  212. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  213. Du, Jinfa; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph, Nucleoside cyclicphosphates.
  214. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  215. Sofia, Michael Joseph; Du, Jinfa; Wang, Peiyuan; Nagarathnam, Dhanapalan, Nucleoside phosphoramidates.
  216. Moneymaker, Ricky Dean; Theus, Jon Scott; Klesman, Larry Scott, Nutrient composition(s) and system(s) for individualized, responsive dosing regimens.
  217. Jamieson, Gene Curtis; Muhammad, Naweed; Bley, Keith R., Oils of capsaicinoids and methods of making and using the same.
  218. Rudnic, Edward M; Isbister, James D; Treacy, Jr., Donald J; Wassink, Sandra E, Once a day amoxicillin product comprising immediate and delayed release dosage forms.
  219. Baheti, Ankit; Padhi, Bijay Kumar; Vakada, Supritha; Raghuvanshi, Rajeev Singh, Oral composition of celecoxib for treatment of pain.
  220. Li, Chi Leung; Martini, Luigi; Re, Vincenzo; Willy, Helen Anne, Oral dosage form for controlled drug release.
  221. Zerbe, Horst G.; Paiement, Nadine, Oral mucoadhesive dosage form.
  222. Coulter, Ivan, Oral pharmaceutical composition.
  223. Coulter, Ivan, Oral pharmaceutical composition.
  224. Coulter, Ivan, Oral pharmaceutical composition.
  225. Vail, Neal K; Vaughn, Dana M, Oral rapamycin nanoparticle preparations.
  226. Vaughn, Dana M, Oral rapamycin preparation and use for stomatitis.
  227. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  228. Dudley, Robert E.; Constantinides, Panayiotis P., Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.
  229. Chen, Jen-Chi; Day, Kenneth; Szymczak, Christopher E., Orally disintegrating tablet.
  230. Bunick, Frank; Luber, Joseph, Orally disintegrative dosage form.
  231. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  232. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  233. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  234. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  235. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  236. Cruise, Gregory M.; Plotkin, Steve; Wu, Xinping, Particles.
  237. Cruise, Gregory M.; Plotkin, Steve; Wu, Xinping, Particles.
  238. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  239. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  240. Coulter, Ivan, Pharmaceutical composition of tacrolimus.
  241. Labrie, Fernand, Pharmaceutical compositions.
  242. Labrie, Fernand, Pharmaceutical compositions.
  243. Labrie, Fernand, Pharmaceutical compositions.
  244. Flanner, Henry H.; Guttendorf, Robert; Treacy, Donald; Clausen, Susan P.; Burnside, Beth A., Pharmaceutical compositions and methods for improved bacterial eradication.
  245. Gyurik, Robert J.; Reppucci, Carl, Pharmaceutical compositions and methods for insulin treatment.
  246. Gyurik,Robert J.; Reppucci,Carl, Pharmaceutical compositions and methods for insulin treatment.
  247. Gyurik,Robert J.; Reppucci,Carl, Pharmaceutical compositions and methods for peptide treatment.
  248. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, Pharmaceutical compositions comprising aloe pectins, and methods for their production and use.
  249. Tien, Walter L.; Graham, Richard S.; Chang, James N., Pharmaceutical compositions comprising cyclosporins.
  250. Tien,Walter L.; Graham,Richard; Chang,James N., Pharmaceutical compositions comprising cyclosporins.
  251. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  252. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  253. Mosher, Gerold L; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  254. Levy,Ralph E., Pharmaceutical compositions for bioactive peptide agents.
  255. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  256. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  257. Coulter, Ivan, Pharmaceutical cyclosporin compositions.
  258. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  259. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  260. Dudley, Robert E.; Constantinides, Panayiotis P., Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same.
  261. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  262. Corvari,Vincent; Grandolfi,George; Parikh,Alpa, Pharmaceutical formulations of modafinil.
  263. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  264. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  265. Heacock, Craig S.; Parikh, Alpa B.; Patel, Piyush R., Pharmaceutical formulations of modafinil.
  266. Hall, Warren; Olmstead, Kay; Weston, Laura, Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  267. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  268. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  269. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  270. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  271. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  272. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  273. Moneymaker, Ricky Dean; Klesman, Larry Scott; Theus, Jon Scott, Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens.
  274. Cruise, Gregory M.; Hincapie, Gloria; Harris, Clayton; Wu, Yue, Polymer films.
  275. Cruise, Gregory M.; Hincapie, Gloria; Harris, Clayton; Wu, Yue, Polymer films.
  276. Cruise, Gregory M.; Hincapie, Gloria; Harris, Clayton, Polymer particles.
  277. Cruise, Gregory M.; Hincapie, Gloria; Harris, Clayton, Polymer particles.
  278. Cruise, Gregory M.; Hincapie, Gloria; Harris, Clayton, Polymer particles.
  279. Hincapie, Gloria; Wu, Xinping; Wu, Yue; Cruise, Gregory M., Polymer particles.
  280. Plotkin, Steve; Cruise, Gregory M.; Keeley, Edward Michael; Yu, Renee; Harris, Clayton, Polymer particles.
  281. Plotkin, Steve; Cruise, Gregory M.; Keeley, Edward Michael; Yu, Renee; Harris, Clayton, Polymer particles.
  282. Wang, Zhaolin; Finlay, Warren H., Powder formation by atmospheric spray-freeze drying.
  283. Lee,Byoung Suk; Lee,Ah Ram; Park,Jong Sik; Kim,Eun Ju; Gil,Hyung Joon, Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof.
  284. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  285. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett M.; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  286. Feinerman, Gregg; Barth, Neil; Schiffman, Rhett; Barnett, Pamela S., Prevention and treatment of ocular side effects with a cyclosporin.
  287. Szymczak, Christopher E.; Dave, Vipul; McNally, Gerard P.; Cochran, David B.; Koll, Gregory; Ulrich, Stephen, Process for making tablet using radiofrequency and lossy coated particles.
  288. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  289. Van Der Zon,Monique; Laheij,Erik Jeroen; O'Connor,Paul, Process for the preparation of catalyst microspheres.
  290. Lorenzon, Maurizio, Process for the production of an n-butyric acid compound in micro encapsulated form, for animal or human consumption.
  291. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Progesterone formulations.
  292. Beutler, Ulrich; Penn, Gerhard, Purification process.
  293. Chang, Wonsuk; Naduthambi, Devan; Nagarathnam, Dhanapalan; Pamulapati, Ganapati Reddy; Ross, Bruce S.; Sofia, Michael Joseph; Zhang, Hai-Ren, Purine nucleoside phosphoramidate.
  294. Cao, Bruce X.; Burnside, Beth A.; Wassink, Sandra E.; Baker, Matt R., Robust pellet.
  295. El-Alfy, Mohamed; Labrie, Fernand; Berger, Louise, Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women.
  296. El-Alfy, Mohamed; Labrie, Fernand; Berger, Louise, Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women.
  297. Holm, Per; Norling, Tomas, Solid dosage form comprising a fibrate.
  298. Holm, Per; Norling, Tomas, Solid dosage form comprising a fibrate.
  299. Holm, Per; Norling, Tomas, Solid dosage form comprising a fibrate.
  300. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  301. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  302. Zerbe, Horst; Paiement, Nadine; Angusti, Angela; Long, Cormac, Solid oral film dosage forms and methods for making same.
  303. Fantuzzi, Michael, Solubilized CoQ-10.
  304. Fantuzzi, Michael, Solubilized CoQ-10.
  305. Fantuzzi, Michael, Solubilized CoQ-10.
  306. Fantuzzi, Michael, Solubilized CoQ-10.
  307. Fantuzzi, Michael, Solubilized CoQ-10.
  308. Fantuzzi, Michael, Solubilized CoQ-10.
  309. Fantuzzi, Michael, Solubilized CoQ-10.
  310. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Irani, Neda; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Soluble estradiol capsule for vaginal insertion.
  311. Tantaoui Elaraqi, Khadija; Broze, Guy; Leruite, Audrey, Stabilized active compound.
  312. White, Jay A.; Tabash, Samir P.; Agudoawu, Sammy A.; Melnick, Joel Z., Stabilized modified release vitamin D formulation and method of administering same.
  313. Blatt,Yoav; Pinto,Rika; Safronchik,Oleg; Sedlov,Tanya; Zelkha,Morris, Stable coated microcapsules.
  314. Xu, Jerry; Tidmarsh, George, Stable compositions of famotidine and ibuprofen.
  315. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  316. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  317. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  318. Xu, Jerry; Tidmarsh, George F., Stable compositions of famotidine and ibuprofen.
  319. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  320. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  321. Ross, Bruce S.; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Rachakonda, Suguna; Zhang, Hai-Ren, Stereoselective synthesis of phosphorus containing actives.
  322. Shadiack, Annette; Persicaner, Peter H. R.; Inskeep, Philip B.; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.; Legassie, Jason D., Steroid hormone pharmaceutical composition.
  323. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  324. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  325. Guth, Felicitas; Kolter, Karl; Schönherr, Michael; Müller, Michael Klemens, Storage-stable dust-free homogeneous particulate formulation.
  326. Gelbard, Harris A.; Dewhurst, Stephen; Goodfellow, Val S.; Loweth, Colin J.; Wiemann, Torsten, Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors.
  327. Gelbard, Harris A.; Dewhurst, Stephen; Goodfellow, Val S.; Loweth, Colin; Wiemann, Torsten, Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors.
  328. Gelbard, Harris A.; Dewhurst, Stephen; Goodfellow, Val S.; Loweth, Colin J.; Wiemann, Torsten, Substituted pyrrolo[2,3-b]pyridines as MLK inhibitors.
  329. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  330. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  331. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release compositions.
  332. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  333. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  334. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  335. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  336. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  337. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  338. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  339. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  340. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  341. Lenaerts, Vincent; Ouadji-Nijki, Patricia Laure; Bacon, Jonathan; Ouzérourou, Rachid; Gervais, Sonia; Rahmouni, Miloud; Smith, Damon, Sustained-release tramadol formulations with 24-hour efficacy.
  342. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanapalan, Synthesis of purine nucleosides.
  343. Chun, Byoung-Kwon; Du, Jinfa; Rachakonda, Suguna; Ross, Bruce; Sofia, Michael Joseph; Pamulapati, Ganapati Reddy; Chang, Wonsuk; Zhang, Hai-Ren; Nagarathnam, Dhanpalan, Synthesis of purine nucleosides.
  344. Holm, Per; Norling, Tomas, Tablet comprising a fibrate.
  345. Fanara,Domenico; Guichaux,Anthony; Berwaer,Monique; Deleers,Michel, Tablet comprising cetirizine and pseudoephedrine.
  346. Fanara,Domenico; Guichaux,Anthony; Berwaer,Monique; Deleers,Michel, Tablet comprising cetirizine and pseudoephedrine.
  347. Cao, Bruce; Wassink, Sandra E.; Treacy, Jr., Donald J.; Burnside, Beth A.; Rowlings, Colin E.; Bonck, John A., Tablet for pulsed delivery.
  348. Phadke, Shivaji; Parikh, Vaishnavi, Thyroid hormone oral dosage forms and methods of using the same.
  349. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Topical co-enzyme Q10 formulations and methods of use.
  350. Hsia, Sung Lan; Narain, Niven Rajin; Li, Jie; Russell, Kathryn J.; Woan, Karrune V.; Persaud, Indushekhar, Topical co-enzyme Q10 formulations and methods of use.
  351. Sasaki, Yasuhiko; Matsumura, Yukihiro; Yamazaki, Masaru; Arai, Hiroshi; Kawabata, Shogo; Saito, Masaaki; Okuyama, Hirohisa; Suzuki, Makoto, Topical diclofenac patch.
  352. Nangia, Avinash; Verma, Daya D.; Jacob, Jules, Topiramate compositions and methods of enhancing its bioavailability.
  353. Amadio, Julia; Shadiack, Annette; Persicaner, Peter H. R.; Winneker, Richard; Legassie, Jason; Thorsteinsson, Thorsteinn; Ghanta, Ajay, Transdermal cream.
  354. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Irani, Neda; Sancilio, Frederick D., Transdermal hormone replacement therapies.
  355. Holton, Jr., Darrell, Translucent smokeless tobacco product.
  356. Holton, Jr., Darrell, Translucent smokeless tobacco product.
  357. Holton, Jr., Darrell, Translucent smokeless tobacco product.
  358. Holton, Jr., Darrell Eugene, Translucent smokeless tobacco product.
  359. Gervais, Sonia; Smith, Damon; Rahmouni, Miloud; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh; Ferrada, Angela; Soulhi, Fouzia, Trazodone composition for once a day administration.
  360. Gervais, Sonia; Smith, Damon; Rahmouni, Miloud; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh; Ferrada, Angela; Soulhi, Fouzia, Trazodone composition for once a day administration.
  361. Bishop, Charles W.; Crawford, Keith H.; Messner, Eric J., Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
  362. Bishop, Charles W.; Crawford, Keith H.; Messner, Eric J., Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
  363. El Naggar,Mawaheb M.; Mousa,Ahmed S., Treatment of inflammatory, cancer, and thrombosis disorders.
  364. El-Naggar, Mawaheb M.; Mousa, Ahmed S., Treatment of inflammatory, cancer, and thrombosis disorders.
  365. Lane, Heidi; O'Reilly, Terence; Wood, Jeanette Marjorie, Treatment of solid tumors with rapamycin derivatives.
  366. Lane, Heidi; O'Reilly, Terence; Wood, Jeanette Marjorie, Treatment of solid tumors with rapamycin derivatives.
  367. Lane, Heidi; O'Reilly, Terence; Wood, Jeanette Marjorie, Treatment of solid tumors with rapamycin derivatives.
  368. Lipp, Michael M., Triptan powders for pulmonary delivery.
  369. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  370. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  371. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  372. Fallon, Joan M.; Feltenstein, Richard, Use of lactulose in the treatment of autism.
  373. Fallon, Joan M.; Feltenstein, Richard, Use of lactulose in the treatment of autism.
  374. Bernick, Brian A.; Amadio, Julia M., Vaginal inserted estradiol pharmaceutical compositions and methods.
  375. Mirkin, Sebastian; Amadio, Julia M.; Bernick, Brian A., Vaginal inserted estradiol pharmaceutical compositions and methods.
  376. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  377. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  378. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로